Trials / Completed
CompletedNCT05627076
Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Abionic SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Abionic has developed a targeted, rapid test for pancreatic stone protein (PSP) in human K2-EDTA venous whole blood using the abioSCOPE instrument. Currently no PSP study comparaison has been done between venous and arterial whole blood. Abionic would like to confirm the equivalence of the PSP between venous whole blood and arterial whole blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blood Sampling | Blood samples will be collected for the PSP measurement using the abioSCOPE. |
Timeline
- Start date
- 2022-08-29
- Primary completion
- 2022-10-11
- Completion
- 2022-10-31
- First posted
- 2022-11-25
- Last updated
- 2022-11-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05627076. Inclusion in this directory is not an endorsement.